Moves by developed nations such as the United States to tighten intellectual property laws are threatening to limit production and distribution of generic drugs, which experts say have been and will remain key in the prevention and treatment of HIV/AIDS and currently account for 80 percent of HIV/AIDS treatment. These efforts are taking shape in two spheres. The first is in discussions on the outcome document that member states are expected...

After a government report confirmed major ethical violations in trials of Human Papilloma Virus (HPV) vaccines on Indian schoolgirls, senior doctors are calling for transparency in clinical trials conducted under private-public partnerships. The report is yet to be placed in the public domain, but its contents were revealed early May by senior doctors who assisted in its preparation, sparking outrage among public health advocates and women’s rights groups. HPV is an umbrella...

The Delhi High Court on Monday stayed an order that would have allowed Indians to seek information from the Supreme Court under the country’s Right-to-Information act, rather than under existing court rules, after the top court appealed the ruling. Earlier this month, the Central Information Commission, which oversees the implementation of India’s transparency law, ruled that people seeking information from the court were entitled to use the four-year-old statute if they...

To increase transparency, India’s patent regulator will soon make public details about patented drugs which include whether domestic demand for these medicines is met at a reasonable price. Patent holders in the country are required to submit once every year the so-called working details which include the quantity and value of a product that is sold, manufacturing base, quantity of production or imports, and a statement on whether public requirement has...

United States has placed India, Pakistan, China and nine other countries on the top 'priority watch list' with regard to violations of Intellectual Property Rights (IPR). America's trading partners on the Priority Watch List present the most significant concerns regarding insufficient IPR protection or enforcement, or otherwise limited market access for persons relying on intellectual property protection. Twelve countries-India, Pakistan, China, Russia, Algeria, Argentina, Canada, Chile, Indonesia, Israel, Thailand and Venezuela are...